| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.044 | 0.4 |